Ingrid L. Moll

Ingrid Lynn Moll (born April 17, 1973) is an American lawyer who has served as a judge of the Connecticut Appellate Court since 2018. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Ingrid Moll', query time: 0.02s Refine Results
  1. 1
    Determining the Depth of Injury in Bioengineered Tissue Models of Cornea and Conjunctiva for the Prediction of All Three Ocular GHS Categories.

    Determining the Depth of Injury in Bioengineered Tissue Models of Cornea and Conjunctiva for the Prediction of All Three Ocular GHS Categories. by Michaela Zorn-Kruppa, Pia Houdek, Ewa Wladykowski, Maria Engelke, Melinda Bartok, Karsten R Mewes, Ingrid Moll, Johanna M Brandner

    Published 2014-01-01
    Get full text
    Article
  2. 2
    Parallelized TCSPC for dynamic intravital fluorescence lifetime imaging: quantifying neuronal dysfunction in neuroinflammation.

    Parallelized TCSPC for dynamic intravital fluorescence lifetime imaging: quantifying neuronal dysfunction in neuroinflammation. by Jan Leo Rinnenthal, Christian Börnchen, Helena Radbruch, Volker Andresen, Agata Mossakowski, Volker Siffrin, Thomas Seelemann, Heinrich Spiecker, Ingrid Moll, Josephine Herz, Anja E Hauser, Frauke Zipp, Martin J Behne, Raluca Niesner

    Published 2013-01-01
    Get full text
    Article
  3. 3
    Occludin is involved in adhesion, apoptosis, differentiation and Ca2+-homeostasis of human keratinocytes: implications for tumorigenesis.

    Occludin is involved in adhesion, apoptosis, differentiation and Ca2+-homeostasis of human keratinocytes: implications for tumorigenesis. by Susanne Rachow, Michaela Zorn-Kruppa, Ulrich Ohnemus, Nina Kirschner, Sabine Vidal-y-Sy, Peter von den Driesch, Christian Börnchen, Jürgen Eberle, Michael Mildner, Eik Vettorazzi, Rita Rosenthal, Ingrid Moll, Johanna M Brandner

    Published 2013-01-01
    Get full text
    Article
  4. 4
    Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients

    Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients by Katharina Gorges, Lisa Wiltfang, Tobias M. Gorges, Alexander Sartori, Lina Hildebrandt, Laura Keller, Beate Volkmer, Sven Peine, Anna Babayan, Ingrid Moll, Stefan W. Schneider, Sören Twarock, Peter Mohr, Jens W. Fischer, Klaus Pantel

    Published 2019-10-01
    Get full text
    Article
  5. 5
    A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts.

    A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. by Stefanie Meyer, Thomas J Fuchs, Anja K Bosserhoff, Ferdinand Hofstädter, Armin Pauer, Volker Roth, Joachim M Buhmann, Ingrid Moll, Nikos Anagnostou, Johanna M Brandner, Kristian Ikenberg, Holger Moch, Michael Landthaler, Thomas Vogt, Peter J Wild

    Published 2012-01-01
    Get full text
    Article

Search Tools: